Systematic review of mTOR inhibitor treatment, biomarkers and prophylaxis for tuberous sclerosis complex-associated seizures

被引：0
|
作者：
Zhang, Jingwen [1 ]
机构：
[1] Kings Coll London GKT Sch Med Educ, London, England
来源：
CLINICAL MEDICINE | 2022年 / 22卷
关键词：
EVEROLIMUS; EPILEPSY; ONSET;
D O I：
10.7861/clinmed.22-4-s48
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：S48 / S49
页数：2
相关论文
共 50 条
  • [21] Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review
    Bissler, John J.
    Kingswood, John C.
    THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (04) : 279 - 290
  • [22] Current role of surgery for tuberous sclerosis complex-associated epilepsy
    Specchio, Nicola
    Pavia, Giusy Carfi
    Palma, Luca
    De Benedictis, Alessandro
    Pepi, Chiara
    Conti, Marta
    Marras, Carlo Efisio
    Vigevano, Federico
    Curatolo, Paolo
    PEDIATRIC INVESTIGATION, 2022, 6 (01) : 16 - 22
  • [23] Current role of surgery for tuberous sclerosis complex-associated epilepsy
    Specchio Nicola
    Pavia Giusy Carfi
    de Palma Luca
    De Benedictis Alessandro
    Pepi Chiara
    Conti Marta
    Marras Carlo Efisio
    Vigevano Federico
    Curatolo Paolo
    儿科学研究(英文), 2022, (01) : 16 - 22
  • [24] Is tuberous sclerosis complex-associated autism a preventable and treatable disorder?
    Curatolo, Paolo
    Scheper, Mirte
    Gialloreti, Leonardo Emberti
    Specchio, Nicola
    Aronica, Eleonora
    WORLD JOURNAL OF PEDIATRICS, 2024, 20 (01) : 40 - 53
  • [25] Differentiation of Sporadic Versus Tuberous Sclerosis Complex-Associated Angiomyolipoma
    Rabenou, Rahmin A.
    Charles, Hearns W.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 205 (02) : 292 - 301
  • [26] THE RESEARCH LANDSCAPE OF TUBEROUS SCLEROSIS COMPLEX-ASSOCIATED NEUROPSYCHIATRIC DISORDERS: A COMPREHENSIVE SCOPING REVIEW
    Vanclooster, S.
    Bissell, S.
    Heunis, T.
    Jansen, A.
    DeVries, P. J.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2021, 65 (09) : 810 - 810
  • [27] mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile
    Pawlik, Bartlomiej
    Smyczynska, Urszula
    Grabia, Szymon
    Fendler, Wojciech
    Drozdz, Izabela
    Babol-Pokora, Katarzyna
    Kotulska, Katarzyna
    Jozwiak, Sergiusz
    Borkowska, Julita
    Mlynarski, Wojciech
    Trelinska, Joanna
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [28] Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML)
    Kapoor, Anil
    Girard, Louis
    Lattouf, Jean-Baptiste
    Pei, York
    Rendon, Ricardo
    Card, Paul
    So, Alan
    UROLOGY, 2016, 89 : 19 - 26
  • [29] Everolimus for tuberous sclerosis complex-associated angiomyolipomas: a case series
    Nicholson, C.
    Wood, S.
    BJU INTERNATIONAL, 2014, 113 : 88 - 89
  • [30] Cannabidiol treatment for seizures in tuberous sclerosis complex
    Lattanzi, Simona
    EPILEPSY & BEHAVIOR, 2022, 132
12345